Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Oleo Sci ; 69(9): 1061-1075, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32879197

RESUMO

Our previous studies have shown that α-eleostearic acid (α-ESA; cis-9, trans-11, trans-13 (c9,t11,t13)-conjugated linolenic acid (CLnA)) is converted into c9,t11-conjugated linoleic acid (CLA) in rats. Furthermore, we have demonstrated that the conversion of α-ESA into CLA is a nicotinamide adenine dinucleotide phosphate (NADPH)-dependent enzymatic reaction, which occurs mostly in the rat liver. However, the precise metabolic pathway and enzyme involved have not been identified yet. Therefore, in this study we aimed to determine the role of cytochrome P450 (CYP) in the conversion of α-ESA into c9,t11-CLA using an in vitro reconstitution system containing mouse hepatic microsomes, NADPH, and α-ESA. The CYP4 inhibitors, 17-ODYA and HET0016, performed the highest level of inhibition of CLA formation. Furthermore, the redox partner cytochrome P450 reductase (CPR) inhibitor, 2-chloroethyl ethyl sulfide (CEES), also demonstrated a high level of inhibition. Thus, these results indicate that the NADPH-dependent CPR/CYP4 system is responsible for CLA formation. In a correlation analysis between the specific activity of CLA formation and Cyp4 family gene expression in tissues, Cyp4a14 and Cyp4f13 demonstrated the best correlations. However, the CYP4F substrate prostaglandin A1 (PGA1) exhibited the strongest inhibitory effect on CLA formation, while the CYP4A and CYP4B1 substrate lauric acid had no inhibitory effect. Therefore, we conclude that the CYP4F13 enzyme is the major enzyme involved in CLA formation. This pathway is a novel pathway for endogenous CLA synthesis, and this study provides insight into the potential application of CLnA in functional foods.


Assuntos
Família 4 do Citocromo P450/farmacologia , Ácidos Linoleicos Conjugados/metabolismo , Ácidos Linolênicos/metabolismo , Microssomos Hepáticos/metabolismo , Animais , Família 4 do Citocromo P450/genética , Família 4 do Citocromo P450/metabolismo , Família 4 do Citocromo P450/fisiologia , Expressão Gênica , Técnicas In Vitro , Camundongos Endogâmicos ICR , NADP/metabolismo
2.
Elife ; 92020 04 07.
Artigo em Inglês | MEDLINE | ID: mdl-32252890

RESUMO

Meibum lipids form a lipid layer on the outermost side of the tear film and function to prevent water evaporation and reduce surface tension. (O-Acyl)-ω-hydroxy fatty acids (OAHFAs), a subclass of these lipids, are thought to be involved in connecting the lipid and aqueous layers in tears, although their actual function and synthesis pathway have to date remained unclear. Here, we reveal that the fatty acid ω-hydroxylase Cyp4f39 is involved in OAHFA production. Cyp4f39-deficient mice exhibited damaged corneal epithelium and shortening of tear film break-up time, both indicative of dry eye disease. In addition, tears accumulated on the lower eyelid side, indicating increased tear surface tension. In Cyp4f39-deficient mice, the production of wax diesters (type 1ω and 2ω) and cholesteryl OAHFAs was also impaired. These OAHFA derivatives show intermediate polarity among meibum lipids, suggesting that OAHFAs and their derivatives contribute to lipid polarity gradient formation for tear film stabilization.


Assuntos
Família 4 do Citocromo P450/fisiologia , Síndromes do Olho Seco/prevenção & controle , Ácidos Graxos/química , Lágrimas/química , Animais , Família 4 do Citocromo P450/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout
3.
Bioorg Med Chem Lett ; 29(19): 126616, 2019 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-31439380

RESUMO

19-Hydroxyeicosatetraenoic acid (19-HETE, 1), a metabolically and chemically labile cytochrome P450 eicosanoid, has diverse biological activities including antagonism of the vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE, 2). A SAR study was conducted to develop robust analogs of 1 with improved in vitro and in vivo efficacy. Analogs were screened in vitro for inhibition of 20-HETE-induced sensitization of rat renal preglomerular microvessels toward phenylephrine and demonstrated to normalize the blood pressure of male Cyp4a14(-/-) mice that display androgen-driven, 20-HETE-dependent hypertension.


Assuntos
Anti-Hipertensivos/química , Anti-Hipertensivos/farmacologia , Família 4 do Citocromo P450/fisiologia , Hipertensão/tratamento farmacológico , Glomérulos Renais/efeitos dos fármacos , Microvasos/efeitos dos fármacos , Animais , Ácidos Hidroxieicosatetraenoicos/toxicidade , Hipertensão/induzido quimicamente , Hipertensão/patologia , Glomérulos Renais/irrigação sanguínea , Masculino , Camundongos , Camundongos Knockout , Fenilefrina/toxicidade , Vasoconstritores/toxicidade
4.
Asia Pac J Ophthalmol (Phila) ; 5(4): 245-52, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27228076

RESUMO

Bietti crystalline dystrophy (BCD) is an inherited retinal degenerative disease characterized by crystalline deposits in the retina, followed by progressive atrophy of the retinal pigment epithelium (RPE), choriocapillaris, and photoreceptors. CYP4V2 has been identified as the causative gene for BCD. The CYP4V2 gene belongs to the cytochrome P450 superfamily and encodes for fatty acid ω-hydroxylase of both saturated and unsaturated fatty acids. The CYP4V2 protein is localized most abundantly within the endoplasmic reticulum in the RPE and is postulated to play a role in the physiological lipid recycling system between the RPE and photoreceptors to maintain visual function. Electroretinographic assessments have revealed progressive dysfunction of rod and cone photoreceptors in patients with BCD. Several genotypes have been associated with more severe phenotypes based on clinical and electrophysiological findings. With the advent of multimodal imaging with spectral domain optical coherence tomography, fundus autofluorescence, and adaptive optics scanning laser ophthalmoscopy, more precise delineation of BCD severity and progression is now possible, allowing for the potential future development of targets for gene therapy.


Assuntos
Distrofias Hereditárias da Córnea/genética , Citocromo P-450 CYP4A/fisiologia , Família 4 do Citocromo P450/genética , Doenças Retinianas/genética , Distrofias Hereditárias da Córnea/patologia , Distrofias Hereditárias da Córnea/fisiopatologia , Citocromo P-450 CYP4A/metabolismo , Família 4 do Citocromo P450/fisiologia , Eletrorretinografia , Retículo Endoplasmático/metabolismo , Humanos , Mutação , Células Fotorreceptoras Retinianas Cones/fisiologia , Doenças Retinianas/patologia , Doenças Retinianas/fisiopatologia , Epitélio Pigmentado da Retina/metabolismo , Células Fotorreceptoras Retinianas Bastonetes/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...